Lv72
4550 积分 2021-09-07 加入
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology
10天前
已完结
CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
11天前
已完结
Ocular toxicities of fibroblast growth factor receptor inhibitors: A review
12天前
已完结
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
13天前
已完结
Integration of multi-omics for precision therapy in breast cancer
17天前
已关闭
Advances in Payload and Linker Designs for ADCs
17天前
已完结
Targeting CD30/CD30L in Oncology and Autoimmune and Inflammatory Diseases
19天前
已完结
The biology of TREM receptors
19天前
已完结
Predictors of Chronic Pain in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Prospective Observational Study
25天前
已完结
Tegileridine: First Approval
26天前
已完结
皖公网安备34019202002308
